Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Stryker Corp

SYK ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$339.21

▼ -0.55%

Market Cap $130.11B · Vol 554.63K

Key Metrics

P/E Ratio

35.15

FWD: 21.09

Market Cap

$130.11B

Large Cap

Div Yield

1.03%

Quarterly dividend

EPS Growth

+10.21%

YoY

RSI (14)

51.47

Momentum

Beta

0.77

vs Market

52W High

$396.56

14.46% below

52W Low

$281.04

20.70% above

Volume

554.63K

Avg 607.63K

P/B

6.00

Price-to-book

ROE

24.47%

Return on equity

Free Float

94.57%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Stryker Corp (SYK) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SYK pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.05%

+9.05%

+11.03%

-7.33%

YTD

-3.49%

-10.39%

+19.08%

+28.90%

Financials & Valuation

TTM · Annual

Total Revenue	$25.12B
Net Income	$3.25B
Revenue Growth (YoY)	+9.42%
Gross Margin	62.35%
Operating Margin	23.38%
Net Profit Margin	12.92%
ROE	24.47%
ROA · ROIC	9.94% · 10.16%

P/E Ratio	35.15
Forward P/E (FY1)	21.09
PEG Ratio	5.10
P/S	5.41
P/B	6.00
P/FCF	31.72
EPS Growth	+10.21%
Outstanding Shares	383.57M

Technical Indicators

50-Day SMA	$324.02
200-Day SMA	$341.33
RSI (14)	51.47
Beta	0.77
52-Week High	$396.56
52-Week Low	$281.04

Volume Today	554.63K
Avg Daily Volume (30D)	607.63K
Relative Volume	0.91x
Volatility (10D)	27.67
Volatility (30D)	40.74
Free Float	94.57%

Analyst Consensus

BUY

Current Price $339.21

Mean Target $384.82

52W Low$281.04 52W High$396.56

Current

Target

$281.04 $396.56

Current Analyst target

+13.45% upside potential · 31 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S8FR03

ISINUS8636671013

CountryUnited States of America

Sub-IndustryMedical Devices & Implants

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SN-.L Smith & Nephew PLC -0.86% SNN Smith & Nephew PLC -1.00% GKOS Glaukos Corp -2.60% 300896.SZ Imeik Technology Development Co Ltd -2.43% 002901.SZ Double Medical Technology Inc -0.88%

Company Profile

Stryker Corporation is a medical technology company. It offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and others. It offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs. It is also focused on treating calcified arterial disease.